10 noviembre 2014
Neuroscientists discovered that statins, a popular class of cholesterol drugs, reverse the learning deficits caused by a mutation linked to a common genetic cause of learning disabilities. The findings were studied in mice genetically engineered to develop the disease, called Noonan syndrome.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/XWFTvlPMg74/141110124235.htm
